Form4insider filings, from the source

SEC Form 4 · accession 0001209191-18-051221

Bellerophon Therapeutics, Inc. · BLPH

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Nimish P Shah
10% Owner
Period of report
Sep 13, 2018
Accepted (ET)
Sep 17, 2018 · 4:46 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001600132

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2,F3Sep 13, 2018P75,000$1.1888A7,251,163IBy funds
Common StockF2,F3Sep 14, 2018P75,000$1.23A7,326,163IBy funds
Common StockF3,F4Sep 17, 2018P60,000$1.1824A7,386,163IBy funds

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses